TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Wanbury Limited ( (IN:WANBURY) ) is now available.
Wanbury Limited has announced the appointment of two new Non-Executive Independent Directors, Mr. Manojkumar Khubchand Gursahani and Mr. Pallavur Sankar Dass Vaidyanathan. Mr. Gursahani will serve a term of one year, while Mr. Vaidyanathan will have a three-year term. This decision, approved in an Extra-Ordinary General Meeting, reflects the company’s efforts to strengthen its board with seasoned professionals. Such appointments could enhance strategic decision-making and governance, potentially impacting the company’s long-term growth and market positioning.
More about Wanbury Limited
Wanbury Limited operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical formulations and active pharmaceutical ingredients. The company is headquartered in Navi Mumbai, India, and is engaged in extensive R&D activities to offer a range of healthcare solutions.
YTD Price Performance: -31.08%
Average Trading Volume: 22,718
Current Market Cap: 6.4B INR
See more data about WANBURY stock on TipRanks’ Stock Analysis page.